| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 2407039-29-4 | Tofacitinib Impurity 45 | CP-690550 N-Hydroxyl Tofacitinib Impurity 45 (3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile | ||
| 2 | 1640971-51-2 | Tofacitinib metabolite-1 | Tofatinib impurity Tofatinib Impurity 32 Tofacitinib Impurity 77 Tofacitinib metabolite-1 Azilsartan medoxomil impurity322 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-6-oxo-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)- 3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | ||
| 3 | 361481-40-5 | ethyl ethyl-4-(4-toluidino)quinoline-3-carboxylate | ethyl ethyl-4-(4-toluidino)quinoline-3-carboxylate | ||
| 4 | 4,4'-[1,2-Ethanediylbis(oxy)]bis[3-aminobenzamidine] | 4,4'-[1,2-Ethanediylbis(oxy)]bis[3-aminobenzamidine] | |||
| 5 | 1164099-00-6 | 4,4'-bis[(2-aminoethyl)aminocarbonyl]-2,2'-bipyridine | 4,4'-bis[(2-aminoethyl)aminocarbonyl]-2,2'-bipyridine | ||
| 6 | 2,4-Diamino-6-ethyl-5-(3-nitro-4-(pyrrolidin-1-yl)phenyl)pyrimidine | 2,4-Diamino-6-ethyl-5-(3-nitro-4-(pyrrolidin-1-yl)phenyl)pyrimidine | |||
| 7 | 1-(2-Dimethylaminoethyl)-2-(5-nitro-1-ethyl-1H-imidazol-2-yl)-1H-benzimidazole | 1-(2-Dimethylaminoethyl)-2-(5-nitro-1-ethyl-1H-imidazol-2-yl)-1H-benzimidazole | |||
| 8 | 956371-02-1 | 4-[4-(3,4-DIMETHOXYBENZYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-METHYL-1H-PYRAZOL-5-AMINE | 4-[4-(3,4-DIMETHOXYBENZYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-METHYL-1H-PYRAZOL-5-AMINE 4-[4-(3,4-DIMETHOXYBENZYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-METHYL-1H-PYRAZOL-5-YLAMINE 4-[4-[(3,4-dimethoxyphenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-2-methylpyrazol-3-amine | ||
| 9 | 866040-05-3 | ETHYL 4-([3-(1H-IMIDAZOL-1-YL)PROPYL]AMINO)-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE | ETHYL 4-([3-(1H-IMIDAZOL-1-YL)PROPYL]AMINO)-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid, 4-[[3-(1H-imidazol-1-yl)propyl]amino]-1-methyl-, ethyl ester | ||
| 10 | 2028267-73-2 | N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide | Tofacitinib-23 Tofacitinib N-Oxide Tofacitib related impurities 8 N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R) 3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile) | ||
| 11 | 1269823-96-2 | 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-6-oxo-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo- | Tofatib impurity 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-6-oxo-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo- |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|